Noa Hurvitz

407 total citations
16 papers, 295 citations indexed

About

Noa Hurvitz is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, Noa Hurvitz has authored 16 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 2 papers in Infectious Diseases. Recurrent topics in Noa Hurvitz's work include Health Systems, Economic Evaluations, Quality of Life (2 papers), Genomics and Rare Diseases (1 paper) and Neonatal and fetal brain pathology (1 paper). Noa Hurvitz is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (2 papers), Genomics and Rare Diseases (1 paper) and Neonatal and fetal brain pathology (1 paper). Noa Hurvitz collaborates with scholars based in Israel, United States and Germany. Noa Hurvitz's co-authors include Yaron Ilan, Tama Dinur, Ari Zimran, Shoshana Revel‐Vilk, Michal Becker‐Cohen, Marina Hovakimyan, Claudia Cozma, Arndt Rolfs, Marc Berg and Hillel S. Lehmann and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and International Journal of Molecular Sciences.

In The Last Decade

Noa Hurvitz

16 papers receiving 292 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noa Hurvitz Israel 8 98 90 42 36 34 16 295
Ariel Kenig Israel 8 99 1.0× 32 0.4× 34 0.8× 9 0.3× 27 0.8× 19 303
Brandon Jew United States 7 221 2.3× 48 0.5× 41 1.0× 3 0.1× 58 1.7× 11 447
Ting Lin China 12 157 1.6× 50 0.6× 44 1.0× 23 0.6× 19 0.6× 42 396
Jinpeng Liu China 11 188 1.9× 40 0.4× 47 1.1× 15 0.4× 23 0.7× 42 371
Katharine A. Kott Australia 11 120 1.2× 37 0.4× 87 2.1× 4 0.1× 22 0.6× 23 321
Georgios Fildisis Greece 6 111 1.1× 75 0.8× 12 0.3× 7 0.2× 7 0.2× 10 301
Daryl S. Spinner United States 13 305 3.1× 183 2.0× 13 0.3× 25 0.7× 29 0.9× 30 564
Brunilda Balliu United States 12 225 2.3× 23 0.3× 23 0.5× 12 0.3× 158 4.6× 27 479
Hong Mao China 11 94 1.0× 60 0.7× 74 1.8× 36 1.0× 24 0.7× 28 364

Countries citing papers authored by Noa Hurvitz

Since Specialization
Citations

This map shows the geographic impact of Noa Hurvitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noa Hurvitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noa Hurvitz more than expected).

Fields of papers citing papers by Noa Hurvitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noa Hurvitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noa Hurvitz. The network helps show where Noa Hurvitz may publish in the future.

Co-authorship network of co-authors of Noa Hurvitz

This figure shows the co-authorship network connecting the top 25 collaborators of Noa Hurvitz. A scholar is included among the top collaborators of Noa Hurvitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noa Hurvitz. Noa Hurvitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
2.
Hurvitz, Noa, Heather K. Lehman, Khurram Jamil, et al.. (2025). A constrained disorder principle-based second-generation artificial intelligence digital medical cannabis system: A real-world data analysis. Journal of public health research. 14(2). 1224438696–1224438696. 2 indexed citations
3.
Hurvitz, Noa, et al.. (2024). Investigating the Relationship between Chronic Liver Cirrhosis and Parkinsonism: A Comparative Analysis and a Suggested Diagnostic Scheme. SHILAP Revista de lepidopterología. 14(4). 1375–1382. 2 indexed citations
4.
Hurvitz, Noa, Tama Dinur, Shoshana Revel‐Vilk, et al.. (2024). A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy. Journal of Clinical Medicine. 13(11). 3325–3325. 13 indexed citations
5.
Gelman, Ram, Noa Hurvitz, Dean Nachman, et al.. (2023). A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial. Biomedicine & Pharmacotherapy. 161. 114334–114334. 27 indexed citations
6.
Hurvitz, Noa & Yaron Ilan. (2023). The Constrained-Disorder Principle Assists in Overcoming Significant Challenges in Digital Health: Moving from “Nice to Have” to Mandatory Systems. SHILAP Revista de lepidopterología. 13(4). 994–1014. 20 indexed citations
7.
Gross, Itai, Noa Hurvitz, Zivanit Ergaz, et al.. (2023). Serious Bacterial Infections in Preterm Infants: Should Their Age Be “Corrected”?. Journal of Clinical Medicine. 12(9). 3242–3242. 2 indexed citations
9.
Hurvitz, Noa, et al.. (2022). Improving the effectiveness of anti-aging modalities by using the constrained disorder principle-based management algorithms. SHILAP Revista de lepidopterología. 3. 1044038–1044038. 24 indexed citations
10.
Kenig, Ariel, et al.. (2022). Massive Intestinal Bleeding in an Adult with IgA Vasculitis Treated with Intravenous Immunoglobulin. SHILAP Revista de lepidopterología. 2022. 1–4. 2 indexed citations
11.
Hurvitz, Noa, et al.. (2021). Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases. European Journal of Human Genetics. 29(10). 1485–1490. 67 indexed citations
12.
Hurvitz, Noa, Itai Gross, Orli Megged, et al.. (2021). The role of Staphylococcus lugdunensis as a pathogen in children: a multicentre retrospective study. Journal of Medical Microbiology. 70(5). 3 indexed citations
13.
Tankel, James, et al.. (2020). Predicting Weight Loss and Comorbidity Improvement 7 Years Following Laparoscopic Sleeve Gastrectomy: Does Early Weight Loss Matter?. Obesity Surgery. 30(7). 2505–2510. 7 indexed citations
14.
Gross, Itai, et al.. (2020). Tickborne Relapsing Fever, Jerusalem, Israel, 2004–2018. Emerging infectious diseases. 26(10). 2420–2423. 4 indexed citations
15.
Hurvitz, Noa, Tama Dinur, Michal Becker‐Cohen, et al.. (2019). Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease. International Journal of Molecular Sciences. 20(12). 3033–3033. 55 indexed citations
16.
Horwitz, E. Philip, Lars Krogvold, Avital Swisa, et al.. (2018). β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes. Diabetes. 67(11). 2305–2318. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026